MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,275,969 | +38.0% | 5,699,632 | +14.5% | 0.01% | +50.0% |
| Q2 2023 | $179,865,075 | -4.2% | 4,978,275 | -1.4% | 0.00% | -20.0% |
| Q1 2023 | $187,735,762 | -16.7% | 5,049,375 | +1.5% | 0.01% | -16.7% |
| Q4 2022 | $225,366,865 | -31.8% | 4,973,888 | +5.2% | 0.01% | -40.0% |
| Q3 2022 | $330,225,000 | +8.2% | 4,728,299 | +4.0% | 0.01% | +11.1% |
| Q2 2022 | $305,308,000 | -17.2% | 4,548,021 | +1.5% | 0.01% | 0.0% |
| Q1 2022 | $368,577,000 | -43.4% | 4,482,810 | +1.0% | 0.01% | -40.0% |
| Q4 2021 | $651,154,000 | -11.0% | 4,438,977 | +7.3% | 0.02% | -16.7% |
| Q3 2021 | $732,028,000 | +9.6% | 4,137,857 | +0.1% | 0.02% | +5.9% |
| Q2 2021 | $667,834,000 | -6.9% | 4,134,423 | -1.3% | 0.02% | -10.5% |
| Q1 2021 | $717,265,000 | -19.0% | 4,187,185 | +3.8% | 0.02% | -26.9% |
| Q4 2020 | $885,640,000 | +59.5% | 4,032,238 | +20.6% | 0.03% | +44.4% |
| Q3 2020 | $555,290,000 | +41.0% | 3,344,122 | -3.0% | 0.02% | +28.6% |
| Q2 2020 | $393,796,000 | +50.5% | 3,449,202 | +1.3% | 0.01% | +27.3% |
| Q1 2020 | $261,621,000 | -33.8% | 3,403,438 | +10.9% | 0.01% | -15.4% |
| Q4 2019 | $395,293,000 | +67.0% | 3,067,611 | +1.0% | 0.01% | +44.4% |
| Q3 2019 | $236,668,000 | -23.0% | 3,037,721 | +1.8% | 0.01% | -25.0% |
| Q2 2019 | $307,404,000 | +92.2% | 2,984,506 | +36.8% | 0.01% | +100.0% |
| Q1 2019 | $159,944,000 | +163.3% | 2,182,038 | +52.4% | 0.01% | +100.0% |
| Q4 2018 | $60,747,000 | -9.9% | 1,432,016 | +0.0% | 0.00% | 0.0% |
| Q3 2018 | $67,443,000 | -2.7% | 1,431,905 | +1.9% | 0.00% | 0.0% |
| Q2 2018 | $69,295,000 | +121.6% | 1,405,589 | +38.0% | 0.00% | +200.0% |
| Q1 2018 | $31,264,000 | +68.0% | 1,018,391 | -0.1% | 0.00% | 0.0% |
| Q4 2017 | $18,614,000 | +65.8% | 1,019,914 | +6.3% | 0.00% | 0.0% |
| Q3 2017 | $11,230,000 | +372.4% | 959,807 | +47.3% | 0.00% | – |
| Q2 2017 | $2,377,000 | -33.3% | 651,417 | -4.9% | 0.00% | – |
| Q1 2017 | $3,562,000 | +43.2% | 685,115 | +30.8% | 0.00% | – |
| Q4 2016 | $2,488,000 | -49.9% | 523,812 | -30.3% | 0.00% | – |
| Q3 2016 | $4,969,000 | +45.8% | 751,697 | +20.5% | 0.00% | – |
| Q2 2016 | $3,407,000 | -71.4% | 624,044 | +12.2% | 0.00% | -100.0% |
| Q1 2016 | $11,905,000 | -29.4% | 556,315 | +4.2% | 0.00% | 0.0% |
| Q4 2015 | $16,871,000 | +16.6% | 533,891 | +27.0% | 0.00% | 0.0% |
| Q3 2015 | $14,471,000 | +57.1% | 420,424 | +43.6% | 0.00% | 0.0% |
| Q2 2015 | $9,213,000 | +12.8% | 292,762 | +5.1% | 0.00% | 0.0% |
| Q1 2015 | $8,167,000 | +104.1% | 278,554 | +29.0% | 0.00% | – |
| Q4 2014 | $4,001,000 | +6.6% | 216,016 | +0.8% | 0.00% | – |
| Q3 2014 | $3,754,000 | -10.7% | 214,358 | +2.0% | 0.00% | – |
| Q2 2014 | $4,202,000 | +14.0% | 210,098 | +8.7% | 0.00% | – |
| Q1 2014 | $3,685,000 | +23.7% | 193,250 | +7.9% | 0.00% | – |
| Q4 2013 | $2,980,000 | +805.8% | 179,181 | +724.5% | 0.00% | – |
| Q3 2013 | $329,000 | – | 21,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |